Novo Nordisk sues Eli Lilly over GLP-1 ads
Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group | Getty Images Novo Nordisk on Tuesday filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superior efficacy relative to the…